Form 8-K - Current report:
SEC Accession No. 0001645113-24-000033
Filing Date
2024-10-30
Accepted
2024-10-30 07:02:07
Documents
16
Period of Report
2024-10-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvcr-20241029.htm   iXBRL 8-K 34026
2 EX-10.1 ex101brackmannemploymentag.htm EX-10.1 108760
3 EX-99.1 nvcr-20240930xpr1.htm EX-99.1 140446
4 EX-99.2 ex992pressreleaseannouncin.htm EX-99.2 8914
  Complete submission text file 0001645113-24-000033.txt   459119

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvcr-20241029.xsd EX-101.SCH 1882
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvcr-20241029_lab.xml EX-101.LAB 21801
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvcr-20241029_pre.xml EX-101.PRE 12579
18 EXTRACTED XBRL INSTANCE DOCUMENT nvcr-20241029_htm.xml XML 2707
Mailing Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF
Business Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF 44 (0)15 3475 6700
NovoCure Ltd (Filer) CIK: 0001645113 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37565 | Film No.: 241407409
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)